CG

Chilukuri Geetha Bhavani

Active Director Director DIN 10747193
DIN 10747193 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chilukuri Geetha Bhavani

Data last updated:

Chilukuri Geetha Bhavani is a Director at Kasam Therapeutics Private Limited (since 2024).

DIN 10747193
Primary Designation Director
First Appointment 19 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kasam Therapeutics Private Limited U46497TS2024PTC188601
Director19 Aug 20242024Active

Board colleagues of Chilukuri Geetha Bhavani

NameDINCompanyDesignation
Krishna Babu Duggirala10747194Kasam Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kasam Therapeutics Private Limited
Premium access

Shareholding and investment profile for Chilukuri Geetha Bhavani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chilukuri Geetha Bhavani

Chilukuri Geetha Bhavani currently holds 1 directorship: Kasam Therapeutics Private Limited (Director, since 19 Aug 2024).

Chilukuri Geetha Bhavani was first appointed on 19 Aug 2024 as Director at Kasam Therapeutics Private Limited.

The current boards of Chilukuri Geetha Bhavani's companies include Krishna Babu Duggirala (Kasam Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available